Labelling - Patient information leaflet - Document - PDFSEARCH.IO

First Page		Document Content
Date: 2014-12-27 09:47:37 Research Biosimilar Biotechnology Drugs Pharmaceutical industry Biologic European Medicines Agency Summary of Product Characteristics Patient information leaflet Pharmacology Pharmaceutical sciences Clinical research		Labelling & Naming – European Biosimilars Group (EBG) perspective >400 Million patient days worldwide clinical experience with EU biosimilar medicines Add to Reading List Source URL: www.egagenerics.com Download Document from Source Website File Size: 1,93 MB Share Document on Facebook

	EMLA Cream Additional patient guidance for use in premature ejaculation ● This leaflet contains important information on using EMLA Cream to treat premature ejaculation. DocID: 1vl0i - View Document
	Package leaflet: Information for the patient Spedra 50 mg tablets Spedra 100 mg tablets Spedra 200 mg tablets avanafil Read all of this leaflet carefully before you start taking this medicine because it contains DocID: 1v0tb - View Document
	Communicating the quality of evidence May 2015 Whatever type of information you’re producing – whether it’s an in-depth decision aid or a one-page patient leaflet – you’re bound to be basing at least part of it DocID: 1tX75 - View Document
	Leaflet (FR) NOTICE : INFORMATION DU PATIENT Sildenafil Teva 25 mg comprimés à croquer Sildenafil Teva 50 mg comprimés à croquer Sildenafil Teva 100 mg comprimés à croquer DocID: 1tTOq - View Document
	Leaflet (FR) NOTICE : INFORMATION DU PATIENT Sildenafil Teva 25 mg comprimés à croquer Sildenafil Teva 50 mg comprimés à croquer Sildenafil Teva 100 mg comprimés à croquer DocID: 1tP3F - View Document